Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Mol Oncol. 2015 Oct 28;10(2):272–281. doi: 10.1016/j.molonc.2015.10.007

Figure 5. SecinH3 inhibited tumor growth, but not tumor cell proliferation.

Figure 5

(A) MTT cell proliferation assays of SecinH3 treatment in PyMT cells in 96-well plates. SecinH3 relative dosage of in vivo experiments is about 2.2μM. (B) Tumor volume of PyMT tumor in C57BL/6 mice with or without SecinH3 treatment. N = 5 mice were analyzed in each group. (C) Left: Representative PyMT tumors of vehicle and SecinH3 treatment groups. Right: PyMT tumor weight at end of study. (D) Body weight of mice bearing PyMT tumors, with or without treatment of SecinH3. N = 5 mice were analyzed in each group. (*p<0.05, N.S.: non-significant)